UnknownNot Applicable

Enhanced Detection of Underlying, Covert ATrial Fibrillation Using 7-day Holter Electrocardiogram in Patients With Embolic Stroke of Undetermined Source

Japan200 participantsStarted 2014-08

Plain-language summary

The aim of this study is to determine the diagnostic yield of continuous 7-day Holter ECG for detecting covert paroxysmal atrial fibrillation in patients with recent embolic stroke or transient ischemic attack (TIA) of undetermined cause after completion of a standard clinical work up including an initial 24-hour Holter monitoring.

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Recent ESUS (within 3 months of onset) defined as:
✓. 20 years of age or older
✓. Signed written informed consent

Exclusion criteria

✕. Previously documented atrial fibrillation
✕. Untreated hyperthyroidism
✕. Pacemaker or implantable cardioverter defibrillator implanted or planned to implant
✕. Estimated life expectancy \< 12 months
✕. Examination of seven-day Holter ECG not applicable within 3 months after stroke onset.
✕. Patients considered inappropriate to participate in the study

What they're measuring

Detection of any atrial fibrillation

Timeframe: After examination of 7-day Holter monitoring (within 90 days of stroke onset)

Trial details

NCT IDNCT02801708

SponsorNational Cerebral and Cardiovascular Center, Japan

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-03

Contact for this trial

Yuichi Miyazaki, MD

81-6-6833-5012 ymiyazaki@ncvc.go.jp

View on ClinicalTrials.gov More Stroke trials